Multiplex detection of IgM and IgG class antibodies to Toxoplasma gondii, rubella virus, and cytomegalovirus using a novel multiplex flow immunoassay

Clinical and Vaccine Immunology

Volumn 17, Issue 11, 2010, Pages 1734-1738

  Binnicker, M J ^a   Jespersen, D J ^a   Harring, J A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; CYTOMEGALOVIRUS; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MULTIPLEX FLOW IMMUNOASSAY; PRIORITY JOURNAL; RUBELLA VIRUS; TOXOPLASMA GONDII; TURNAROUND TIME;

ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; CLINICAL LABORATORY TECHNIQUES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; REAGENT KITS, DIAGNOSTIC; RUBELLA; RUBELLA VIRUS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 78449259089     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00332-10     Document Type: Article

References (23)

1. Abdel-Fattah, S. A., A. Bhat, S. Illanes, J. L. Bartha, and D. Carrington. 2005. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat. Diagn. 25:1028-1031.
2. Averhoff, F., J. Zucker, C. Vellozzi, S. Redd, C. Woodfill, S. Waterman, J. Baggs, M. Weinberg, A. Rodriquez-Lainz, V. Carrion, C. Goto, and S. E. Reef. 2006. Adequacy of surveillance to detect endemic rubella transmission in the United States. Clin. Infect. Dis. 43(Suppl. 3):S151-S157.
3. Berth, M., and E. Bosmans. 2010. Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M. Clin. Vaccine Immunol. 17:559-563.
4. Binnicker, M. J., D. J. Jespersen, and J. A. Harring. 2010. Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2. Clin. Vaccine Immunol. 17:253-257.
5. Doern, G. V., L. Robbie, and L. Marrama. 1994. Comparison of two enzyme immunoassays and two latex agglutination assays for detection of cytomegalovirus antibody. Diagn. Microbiol. Infect. Dis. 20:109-112.
6. Epps, R. E., M. R. Pittelkow, and W. P. Su. 1995. TORCH syndrome. Semin. Dermatol. 14:179-186.
7. Gandhoke, I., R. Aggarwal, S. A. Hussain, S. T. Pasha, P. Sethi, S. Thakur, S. Lal, and S. Khare. 2009. Congenital CMV infection; diagnosis in symptomatic infants. Indian. J. Med. Microbiol. 27:222-225.
8. Garland, S. M., and G. L. Gilbert. 1993. Investigation of congenital infection - the TORCH screen is not a legitimate test. Paediatric Infectious Diseases Group of the Australasian Society for Infectious Diseases. Med. J. Aust. 159:346-348.
9. Gomez, E., D. J. Jespersen, J. A. Harring, and M. J. Binnicker. 2010. Evaluation of the Bio-Rad BioPlex 2200 syphilis multiplex flow immunoassay for the detection of IgM- and IgG-class antitreponemal antibodies. Clin. Vaccine Immunol. 17:966-968.
10. Hardelid, P., D. Williams, C. Dezateux, W. D. Cubitt, C. S. Peckham, P. A. Tookey, and M. Cortina-Borja. 2008. Agreement of rubella IgG antibody measured in serum and dried blood spots using two commercial enzyme-linked immunosorbent assays. J. Med. Virol. 80:360-364.
11. Kaur, R., N. Gupta, D. Nair, M. Kakkar, and M. D. Mathur. 1999. Screening for TORCH infections in pregnant women: a report from Delhi. Southeast Asian J. Trop. Med. Public Health 30:284-286.
12. Khan, N. A., and S. N. Kazzi. 2000. Yield and costs of screening growth-retarded infants for torch infections. Am. J. Perinatol. 17:131-135.
13. Klutts, J. S., R. S. Liao, W. M. Dunne, Jr., and A. M. Gronowski. 2004. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status. J. Clin. Microbiol. 42:4996-5000.
14. Lagrou, K., M. Bodeus, M. Van Ranst, and P. Goubau. 2009. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays. J. Clin. Microbiol. 47:1695-1699.
15. Landis, J. R., and G. G. Koch. 1977. The measurement of observer agreement for categorical data. Biometrics 33:159-174.
16. Leland, D., M. L. French, M. B. Kleiman, and R. L. Schreiner. 1983. The use of TORCH titers. Pediatrics 72:41-43.
17. McAuley, J., K. Boyer, J. Remington, and R. McLeod. 2009. Toxoplasmosis, p. 2954. In R. Feigin, J. Cherry, G. Demmler-Harrison, and S. Kaplan (ed.), Textbook of pediatric infectious diseases, 6th ed. Saunders, Philadelphia, PA.
18. Montoya, J. G., and J. S. Remington. 2008. Management of Toxoplasma gondii infection during pregnancy. Clin. Infect. Dis. 47:554-566.
19. Montoya, J. G., and J. S. Remington. 1995. Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin. Infect. Dis. 20:781-789.
20. Morgan, E., R. Varro, H. Sepulveda, J. A. Ember, J. Apgar, J. Wilson, L. Lowe, R. Chen, L. Shivraj, A. Agadir, R. Campos, D. Ernst, and A. Gaur. 2004. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 110:252-266.
21. Newton, E. R. 1999. Diagnosis of perinatal TORCH infections. Clin. Obstet. Gynecol. 42:59-70; quiz, 174-175.
22. Roux-Buisson, N., H. Fricker-Hidalgo, A. Foussadier, D. Rolland, A. S. Suchel-Jambon, M. P. Brenier-Pinchart, and H. Pelloux. 2005. Comparative analysis of the VIDAS Toxo IgG IV assay in the detection of antibodies to Toxoplasma gondii. Diagn. Microbiol. Infect. Dis. 53:79-81.
23. Varro, R., R. Chen, H. Sepulveda, and J. Apgar. 2007. Bead-based multianalyte flow immunoassays: the cytometric bead array system. Methods Mol. Biol. 378:125-152.